Janux Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
JANX
CUSIP
47103J105
Type
Equity
Class
COM
Num filings
203
Total reported value, excl. options
$828 M
Manager Report Date Value ($000) Shares Option Type